Information for a competitive industry.

EGA Events

IGPA Events

External Events

Conferences and Events

Up-coming EGA Conferences

 Coming up in 2012

Brussels | 22-23 March 2012

8th EGA Legal Affairs Forum
Recent developments on SPCs:
• SPCs caselaw and legislation update:
- The galanthamine and the memantine decisions
- The Medeva and the Georgetown references to the CJEU
- Paediatric extensions: negative term SPCs
• Combination products in the pipeline - the effect of the Medeva judgment
• Litigating SPCs around Europe - escitalopram case study:
- What is the product/active ingredient? Regulatory and litigation strategies
• Roundtable presentations on national escitalopram SPC cases: Germany, France, The Netherlands, Belgium
Maximising legal professional privilege:
• Privilege in litigation in Europe (General overview, comparing approach in different Member States)
• US perspective on Privilege (US approach to privilege and discovery, issues with cross-border communications in “touch base” rules vs comity rules, practical guidelines for litigants/potential litigants)
• Privilege and European Commission investigations/patent settlement cases (The Akzo Nobel case, practical issues arising from investigations - privilege and disclosure, update on the Commission’s investigations into patent settlements)
Patent enforcement in Europe:
• Views on the review of Directive 2004/48/EC on the enforcement of IP rights
• Views on the changes in the EU patent system: single court and patent with unitary effect
• Update on court cases that impact the industry
Full programme - Register now - Click here for Advertising Exhibition and Sponsorship Opportunities

London | 19-20 April 2012

10th EGA International Symposium on Biosimilar Medicines
with EGA Pre-symposium Workshop "Biosimilars in America: IP Strategy and Due Diligence"
FOR A DECADE, THE PREMIER EU EVENT ON BIOSIMILAR MEDICINES!
Come and meet the EU and international regulators and the leading EU companies in biosimilars.
The pre-symposium workshop will explore the mechanics of the Biologics Act with an emphasis on how the Act relates to the involved intellectual property and how the intellectual property may impact the biosimilar applicant’s strategy for entering the market.
SYMPOSIUM HIGHLIGHTS 2012:
• Get the IMS outlook on the biotechnology and biosimilars global market and its opportunities.
• Become familiar with the roadmap for an EU policy for biosimilars.
• Hear the investors’ insights into mergers & acquisitions and the financial market perspective of the biosimilars market.
• Exchange views on the experience with the national uptake of biosimilars.
• Get a detailed update from the EU regulators on the revised biosimilar guidelines and the adopted biosimilar monoclonal antibodies guideline.
• Learn about the latest status of the US FDA biosimilar guidelines and the developments in Japan and major Latin American countries.
• Join the discussion on the need for a framework supporting global development for biosimilars.
• Come and meet regulators from all over the world and take advantage of networking opportunities within the biosimilar industry.
Full programme - Register now - Click here for Advertising Exhibition and Sponsorship Opportunities

Malta | 13-15 June 2012

18th EGA Annual Conference "Healthy and Active Ageing Through Improved Access to Affordable Generic Medicines"
• KEYNOTE SPEECH - The European Union's vision in the European year for active ageing and solidarity between generations - Commissioner John Dalli, European Commissioner for Health and Consumers
• Society undergoing transformation: how to better match the medicine needs of society and improve healthcare sustainability.
• Price cuts, tendering systems, price reference systems: the way forward to a sustainable generic medicines industry.
• How can European generic and biosimilar medicines companies succeed in a changing world?
• The EU regulatory environment impacting access to generic and biosimilar medicines.
• Future scenarios for the generic and biosimilar medicines industry: viewpoints from analysts.
• CEO PANEL – What is the future of the EU generic and biosimilar medicines industry in the period of global economic upheaval and demographic changes: the views of CEOs from leading generic and biosimilar medicines companies.
More info click here - Click here for Advertising Exhibition and Sponsorship Opportunities

Brussels | 27-28 June 2012

"Quality by design for generic medicines: Building a successful Business Case"- Joint ISPE – EGA Conference
This event is the first in Europe to focus on the practical application of the concept of Quality by Design (QbD) to the pharmaceutical development and manufacturing of generic medicines. It will offer a unique discussion platform for the generic medicines industry and regulators to gain essential updates and clarification on technical elements of QbD, as well as QbD’s regulatory and compliance implications. Registrations will open 15 February 2012 on www.ispe.org/2012QbDeuconference

London | 6 November 2012

4th EMA—EGA Information Day - EGA Members only

IGPA Conferences

Japan | TBC 2012

15th Annual IGPA Conference More info available by the end of 2011

Europe | TBC 2013

16th Annual IGPA Conference More info available by the end of 2012

Past EGA & IGPA Events

2012

London | 18 January 2012

5th EGA Pharmacovigilance Discussion Forum

London | 18 January 2012

7th EGA South East European Pharmaceutical Symposium "Meeting the European Challenge for National Drug Regulatory Agencies and the Generic Medicines Industry" - EGA Members only

London | 19-20 January 2012

11th EGA Regulatory and Scientific Affairs Conference "Meeting New Challenges of the Regulatory Environment"

2011

Cape Town (South Africa) | 1-3 November 2011

14th Annual IGPA Conference

Lisbon - Cascais | 15-17 June 2011

• Press Release

London | 14-15 April 2011

• Press Release

Brussels | 17-18 March 2011

London | 24 January 2011

• Press Release

London | 25-26 January 2011

• Press Release

2010

Mumbai | 8-10 December 2010

13th Annual IGPA Conference More info info@ipa-india.org

Suntec City - Singapore | 27 November 2010

London | 10 November 2010

• EGA members only
• Press Release

Vrsac, Serbia | 30 September - 1 October 20106th EGA South East European Pharmaceutical Symposium

• EGA members only
• Press Release

London | 2-3 September 2010

• Press Release

Rome | 2-4 June 2010 with Welcome Cocktail on 2 June 2010

• Press Release

London | 1 June 2010

• Press Release

Munich | 11 March 2010

• Press Release
  

London | 21-22 January 2010

• Press Release

London | 20 January 2010

London | 20 January 2010

• Press Release

2009

Montreal | 30 September - 2 October 2009

12th Annual IGPA Conference

Ohrid, Macedonia (FYROM) | 24-25 September 2009 5th EGA SE Europe Pharmaceutical Symposium
   
 
 

Barcelona | 3-5 June 2009

• Pre-conference Seminar | Worldwide Generics in a Changing Climate

London | 23–24 April 2009

“Towards Global Development and Monoclonal Antibodies”

• Programme
• Speaker Line-up & CVs
• Press Release

 Munich | 12-13 March 2009

• See: EGA Conference Highlights | 04

Amsterdam | 28 January 2009

• See: EGA Conference Highlights | 04

Amsterdam | 28 January 2009

• See: EGA Conference Highlights | 04

Amsterdam | 29–30 January 2009

• See: EGA Conference Highlights | 04

 

 

2008

Geneva | 8-10 December 2008

• See: EGA Conference Highlights | 04

Paris | 7-8 October 2008

“Bioequivalence guideline revision, regulatory procedures and
good practices: paving the way towards an even more efficient regulatory framework”

• See: EGA Conference Highlights | 03

London: 3 October 2008

“Generic & Biosimilar Medicines in the Centralised Procedure”

• See: EGA Conference Highlights | 03

Paris | 4 June 2008

• See: EGA Conference Highlights | 03

Paris | 2-3 June 2008

“Generic Medicines | Enhancing Pharmaceutical Competition
   and Ensuring Healthcare Sustainability”

• See: EGA Conference Highlights | 02

London | 24–25 April 2008

“Biosimilar Medicines | Developing Market Pathways
   that Benefit Patients”

• See: EGA Conference Highlights | 02

Brussels: 31 Jan–1 Feb 2008

“Developing an Efficient Regulatory System in Europe”

• See: EGA Conference Highlights | 01

 

Brussels: 30 January 2008

• See: EGA Conference Highlights | 01

Brussels: 30 January 2008

“EU Pharmacovigilance: A Moving Target”

• See: EGA Conference Highlights | 01

2007

Miami: 28 Nov-1 Dec 2007

   “Generic Medicines: A Global Market - A Global Industry”

Lisbon: 23-24 October 2007

“Study Design, Working to GCP and Interpreting the Guidelines: The Keys to a Successful Generics Application”

Istanbul: 14-16 June 2007

“Challenges in the European and Global Environment
for the Generic Medicines Industry”

London: 3-4 May 2007

“BIOSIMILAR MEDICINES: Opportunity for Sustainable Healthcare”

• THE biosimilars event of the year!

Brussels: 13-14 February 2007

• Programme Details

Incorporating: 12 February 2007

• Programme Details

2006

London: 24 November 2006

“Generic and Biosimilar Medicines in the Centralised Procedure”

Budapest: 21-22 September 2006

• Press Release

Monaco (Nice): 18-21 June 2006

London: 18-19 May 2006

“Biosimilar Products, a Reality in Europe”

• Programme Details

London: 2-3 February 2006

• Conference Flyer
• Detailed Programme

London: 1 February 2006

» Pre-Conference Seminar: How to approach electronic
submissions with eCTD?

2005

Berlin: 21-22 November 2005

• Programme details
• Presentation Franz Knieps,
  German Ministry of Health
• Presentation Nils Behrndt,
  European Commission

Malta: 19-22 June 2005

• Conference Programme
• Press Release

London: 26-27 May 2005

• Programme Details
• Press Release

London: 2/3-4 February 2005

• Programme Details for both Events

2004

Lisbon: 26 November 2004

Organised by APOGEN in collaboration with EGA

• Opening Keynote Address
  Luís Filipe Pereira, Portuguese Minister for Health [PT] [EN]
• APOGEN Press Release [PT] [EN]
• Conference Programme [PT]

Amsterdam: 8-9 November 2004

“Meeting the Challenge”

• Program Details
• Opening Keynote Address
  J.F. Hoogervorst, Dutch Health Minister

Prague: 28-30 June 2004

7th Annual IGPA
International Generics Conference

London: 28 May 2004

London: 12-13 February 2004

2003

Rome: 10-11 November 2003

“Increasing Patient Access to Affordable Generic Medicines in an Expanding European Union”

Lisbon: 30 June-2 July 2003

London: 23 May 2003

Brussels: 13-14 March 2003

2002

Copenhagen: 19-20 September 2002

“Generic Medicines: Overcoming the
Barriers to Generic Competition in Europe’s Healthcare Market”

Florida, USA: 8-12 April 2002

Programme not available.

London: 14-15 February 2002

2001

Brussels: 20-21 November 2001

“Generic Medicines: Encouraging Competition & Affordability In Europe’s Healthcare Market”

2000

Krakow: 4-6 October 2000